{
    "2021-05-17": [
        [
            {
                "time": "",
                "original_text": "康希诺生物、上海医药向上药康希诺增资约11亿元",
                "features": {
                    "keywords": [
                        "康希诺生物",
                        "上海医药",
                        "增资",
                        "新冠疫苗",
                        "Ad5-nCoV"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "疫苗生产"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上药、白药高层见面会：强强联手启新程",
                "features": {
                    "keywords": [
                        "上海医药",
                        "云南白药",
                        "合作",
                        "战略发展"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药行业",
                        "战略合作"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上海医药大涨",
                "features": {
                    "keywords": [
                        "上海医药",
                        "股价上涨"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药行业"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "抗癌治癌板块活跃，上海医药涨幅居前",
                "features": {
                    "keywords": [
                        "抗癌治癌",
                        "上海医药",
                        "板块活跃"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药行业",
                        "抗癌药物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "西南证券维持云南白药买入评级：投资上海医药，强强联合共促发展",
                "features": {
                    "keywords": [
                        "西南证券",
                        "云南白药",
                        "买入评级",
                        "上海医药",
                        "合作"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药行业",
                        "投资合作"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "八省二区的头孢氨苄“团购”来了；第四批集采未中选药品257个调价，388个暂停挂网；荣昌生物宣布拟赴科创板上市",
                "features": {
                    "keywords": [
                        "头孢氨苄",
                        "集采",
                        "调价",
                        "暂停挂网",
                        "荣昌生物",
                        "科创板上市"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药行业",
                        "政策影响",
                        "资本市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}